ArticleInternational ophthalmology2025
Three-step technique for easy implantation of large optic IOLs.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo demonstrate the surgical technique of the implantation of the trifocal IOL with the 7-mm large optic.
methodsThe retrospective case series study included 94 eyes of 59 patients who underwent the routine laser-assisted cataract surgery through 5.0 mm capsulotomy and were implanted with Triva-aXAY IOL (HumanOptics Holding AG, Erlangen, Germany) using the 3L implantation method. The 3L method consisted of three consecutive steps before and during the IOL implantation. The 3L implantation videos were analysed to determine the surgery course. The visual acuity and dysphotopsia occurrence were assessed at 6 months postoperatively.
resultsThe mean monocular CDVA, DCIVA and DCNVA were 0.0 ± 0.04 logMAR, 0.11 ± 0.12 logMAR and 0.07 ± 0.09 logMAR. Regarding dysphotopsia, 36% of patients reported no dysphotopsia at all. 'No or mild' halo, glare and starburst were reported in 79%, 64% and 64% of patients, respectively. The median time of IOL implantation (IQR) was 47.5 s (39; 68 s).
conclusionsThe innovative 3L implantation technique enables the surgeons to implant the IOL with the large optic or bulky platform easily, safely and without additional manipulation. Video abstract in Supplement online material.
Indexed as
Identifiers
40613948What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.